-
hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2007v2_MaskedStats_IP.PDF
April 09, 2010 - W MCC 1,890 0.18
181: RESPIRATORY NEOPLASMS W CC 2,180 0.21
182: RESPIRATORY NEOPLASMS W/O CC/MCC … FOR NEOPLASM W/O CC/MCC 18 0.00
659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W MCC 255 0.02
660 … : KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W CC 291 0.03
661: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM … W MCC 152 0.01
687: KIDNEY & URINARY TRACT NEOPLASMS W CC 222 0.02
688: KIDNEY & URINARY TRACT NEOPLASMS … function studies 2,449 0.06
210: Other radioisotope scan 155 0.00
211: Therapeutic radiology for cancer
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2004_SummaryStats_10PCT_SEVERITY_A.PDF
January 01, 2004 - electrolyte disorders 800457 0 0.00 1.00 0.13 0.34
CM_METS : AHRQ comorbidity measure: Metastatic
cancer … comorbidity measure: Renal
failure 800457 0 0.00 1.00 0.04 0.19
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … W/O CC 277 0.03
101: NERVOUS SYSTEM NEOPLASMS W CC 772 0.10
102: NERVOUS SYSTEM NEOPLASMS W MCC 197 … W/O CC 260 0.03
821: RESPIRATORY NEOPLASMS W CC 1585 0.20
822: RESPIRATORY NEOPLASMS W MCC 768 0.10 … Parotitis or Benign Tumors 266 0.03
DEN04: Gingival and Periodontal Disease 73 0.01
DEN05: Neoplasm
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2002_SummaryStats_10PCT_SEVERITY_A.PDF
January 01, 2002 - electrolyte disorders 749424 35974 0.00 1.00 0.12 0.32
CM_METS : AHRQ comorbidity measure: Metastatic
cancer … measure: Renal
failure 749424 35974 0.00 1.00 0.03 0.18
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … W/O CC 306 0.04
101: NERVOUS SYSTEM NEOPLASMS W CC 702 0.09
102: NERVOUS SYSTEM NEOPLASMS W MCC 136 … W/O CC 312 0.04
821: RESPIRATORY NEOPLASMS W CC 1540 0.20
822: RESPIRATORY NEOPLASMS W MCC 692 0.09 … DEN02: Dental Disease 168 0.02
DEN03: Diseases of the Salivary Gland or Parotitis Including Benign Tumors
-
hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2007_MaskedStats_IP.PDF
January 01, 2007 - W MCC 1,914 0.18
181: RESPIRATORY NEOPLASMS W CC 2,157 0.21
182: RESPIRATORY NEOPLASMS W/O CC/MCC … FOR NEOPLASM W/O CC/MCC 28 0.00
659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W MCC 234 0.02
660 … : KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W CC 287 0.03
661: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM … W MCC 147 0.01
687: KIDNEY & URINARY TRACT NEOPLASMS W CC 228 0.02
688: KIDNEY & URINARY TRACT NEOPLASMS … function studies 3,755 0.09
210: Other radioisotope scan 223 0.01
211: Therapeutic radiology for cancer
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2004_SummaryStats_10PCT_SEVERITY_B.PDF
January 01, 2004 - electrolyte disorders 800457 0 0.00 1.00 0.13 0.34
CM_METS : AHRQ comorbidity measure: Metastatic
cancer … comorbidity measure: Renal
failure 800457 0 0.00 1.00 0.04 0.19
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … W/O CC 295 0.04
101: NERVOUS SYSTEM NEOPLASMS W CC 773 0.10
102: NERVOUS SYSTEM NEOPLASMS W MCC 171 … W/O CC 261 0.03
821: RESPIRATORY NEOPLASMS W CC 1576 0.20
822: RESPIRATORY NEOPLASMS W MCC 848 0.11 … Parotitis or Benign Tumors 280 0.03
DEN04: Gingival and Periodontal Disease 84 0.01
DEN05: Neoplasm
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2002_SummaryStats_10PCT_SEVERITY_B.PDF
January 01, 2002 - electrolyte disorders 749423 35975 0.00 1.00 0.12 0.32
CM_METS : AHRQ comorbidity measure: Metastatic
cancer … measure: Renal
failure 749423 35975 0.00 1.00 0.03 0.18
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … W/O CC 318 0.04
101: NERVOUS SYSTEM NEOPLASMS W CC 699 0.09
102: NERVOUS SYSTEM NEOPLASMS W MCC 141 … W/O CC 305 0.04
821: RESPIRATORY NEOPLASMS W CC 1552 0.20
822: RESPIRATORY NEOPLASMS W MCC 674 0.09 … DEN02: Dental Disease 172 0.02
DEN03: Diseases of the Salivary Gland or Parotitis Including Benign Tumors
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2003_SummaryStats_10PCT_SEVERITY_B.PDF
January 01, 2003 - electrolyte disorders 756095 41678 0.00 1.00 0.12 0.33
CM_METS : AHRQ comorbidity measure: Metastatic
cancer … measure: Renal
failure 756095 41678 0.00 1.00 0.03 0.18
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … W/O CC 274 0.03
101: NERVOUS SYSTEM NEOPLASMS W CC 737 0.09
102: NERVOUS SYSTEM NEOPLASMS W MCC 143 … W/O CC 285 0.04
821: RESPIRATORY NEOPLASMS W CC 1539 0.19
822: RESPIRATORY NEOPLASMS W MCC 751 0.09 … DEN02: Dental Disease 157 0.02
DEN03: Diseases of the Salivary Gland or Parotitis Including Benign Tumors
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2003_SummaryStats_SEVERITY.PDF
January 01, 2003 - electrolyte disorders 2984129 0 0.00 1.00 0.07 0.25
CM_METS : AHRQ comorbidity measure: Metastatic
cancer … comorbidity measure: Renal
failure 2984129 0 0.00 1.00 0.00 0.05
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … W/O CC 505 0.02
101: NERVOUS SYSTEM NEOPLASMS W CC 607 0.02
102: NERVOUS SYSTEM NEOPLASMS W MCC 121 … W/O CC 84 0.00
821: RESPIRATORY NEOPLASMS W CC 123 0.00
822: RESPIRATORY NEOPLASMS W MCC 52 0.00 … DEN02: Dental Disease 1235 0.04
DEN03: Diseases of the Salivary Gland or Parotitis Including Benign Tumors
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2015Q1Q3_Severity.PDF
October 31, 2017 - electrolyte
disorders 12,927,179 0 0.00 1.00 0.24 0.43
CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 12,927,179 0 0.00 1.00 0.12 0.33
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 9,988 0.08%
110: Ear, nose, mouth, throat, cranial/facial malignancies … 6,987 0.05%
681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 8,696 0.07%
690 … Percent
of Total
692: Radiotherapy 855 0.01%
693: Chemotherapy 53,580 0.41%
694: Lymphatic & other malignancies
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2014_MaskedStats_Severity.PDF
January 01, 2014 - electrolyte
disorders 14,894,613 0 0.00 1.00 0.23 0.42
CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 14,894,613 0 0.00 1.00 0.12 0.32
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 11,999 0.08%
110: Ear, nose, mouth, throat, cranial/facial malignancies … Percent
of Total
692: Radiotherapy 1,074 0.01%
693: Chemotherapy 63,030 0.42%
694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 11,821 0.08%
710: Infectious & parasitic diseases including HIV w
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2012_MaskedStats_Severity.PDF
January 01, 2012 - Variable / Label
N
N
Miss Minimum Maximum Mean Std Dev
CM_METS : AHRQ comorbidity measure: Metastatic
cancer … measure: Renal
failure 7,296,968 0 0.00 1.00 0.10 0.30
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 5,994 0.08%
110: Ear, nose, mouth, throat, cranial/facial malignancies … 3,605 0.05%
681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 4,755 0.07%
690 … Percent
of Total
692: Radiotherapy 706 0.01%
693: Chemotherapy 31,632 0.43%
694: Lymphatic & other malignancies
-
hcup-us.ahrq.gov/reports/methods/2006_1.pdf
January 01, 2006 - For example, if a patient presents with a lump and it is
diagnosed as a malignant neoplasm during the … hospitalization, the malignant neoplasm should
be considered to be present on admission. … For example,
“personal history of malignant neoplasm” cannot develop after admission. … Neoplasm Bronchus or Lung 11,303 11,244 99.48 1,311 1,302 99.3%
174.9 Malignant Neoplasm Breast 4,735 … 4,724 99.77 960 952 99.2%
185 Malignant Neoplasm Prostate 14,486 14,438 99.67 4,855 4,781 98.5%
250.00
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2006_MaskedStats_Severity.PDF
January 01, 2006 - electrolyte disorders 8074825 0 0.00 1.00 0.15 0.36
CM_METS : AHRQ comorbidity measure: Metastatic cancer … comorbidity measure: Renal failure 8074825 0 0.00 1.00 0.07 0.25
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … OTHER EAR, NOSE, MOUTH & THROAT PROCEDURES 7053 0.09
110: EAR, NOSE, MOUTH, THROAT, CRANIAL/FACIAL MALIGNANCIES … WO CC 2841 0.04
101: NERVOUS SYSTEM NEOPLASMS W CC 7532 0.09
102: NERVOUS SYSTEM NEOPLASMS W MCC 1668 … DEN02: Dental Disease 1863 0.02
DEN03: Diseases of the Salivary Gland or Parotitis Including Benign Tumors
-
hcup-us.ahrq.gov/reports/methods/2004-05.pdf
January 01, 2004 - older
Inpatient Quality Indicators
IQI 9 Deaths per 1000 admissions with pancreatic resection for cancer … DRGs with a NIS 1997 benchmark of less than 0.5%
mortality, excluding trauma, immunocompromised, and cancer … PSI 7 Selected infections due to medical care per 1000 discharges* (excluding immunocompromised and cancer … cardiac arrest, poisoning, trauma, delirium, psychoses, anoxic brain injury; patients with metastatic
cancer … , lymphoid malignancy, bone malignancy, and self-inflicted injury.
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2003_SummaryStats_SEVERITY.PDF
January 01, 2003 - electrolyte disorders 7560944 416784 0.00 1.00 0.12 0.33
CM_METS : AHRQ comorbidity measure: Metastatic
cancer … measure: Renal
failure 7560944 416784 0.00 1.00 0.03 0.18
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … W/O CC 2847 0.04
101: NERVOUS SYSTEM NEOPLASMS W CC 7057 0.09
102: NERVOUS SYSTEM NEOPLASMS W MCC … W/O CC 2931 0.04
821: RESPIRATORY NEOPLASMS W CC 15790 0.20
822: RESPIRATORY NEOPLASMS W MCC 7482 … DEN02: Dental Disease 1622 0.02
DEN03: Diseases of the Salivary Gland or Parotitis Including Benign Tumors
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2004_SummaryStats_SEVERITY.PDF
January 01, 2004 - electrolyte disorders 8004571 0 0.00 1.00 0.13 0.34
CM_METS : AHRQ comorbidity measure: Metastatic
cancer … comorbidity measure: Renal
failure 8004571 0 0.00 1.00 0.04 0.19
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … W/O CC 2892 0.04
101: NERVOUS SYSTEM NEOPLASMS W CC 7644 0.10
102: NERVOUS SYSTEM NEOPLASMS W MCC … W/O CC 2755 0.03
821: RESPIRATORY NEOPLASMS W CC 15940 0.20
822: RESPIRATORY NEOPLASMS W MCC 8116 … Parotitis or Benign Tumors 2908 0.04
DEN04: Gingival and Periodontal Disease 813 0.01
DEN05: Neoplasm
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2005_SummaryStats_SEVERITY.PDF
January 01, 2005 - electrolyte disorders 7995048 0 0.00 1.00 0.14 0.35
CM_METS : AHRQ comorbidity measure: Metastatic
cancer … comorbidity measure: Renal
failure 7995048 0 0.00 1.00 0.04 0.20
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … WO CC 2805 0.04
101: NERVOUS SYSTEM NEOPLASMS W CC 7642 0.10
102: NERVOUS SYSTEM NEOPLASMS W MCC 1733 … WO CC 2478 0.03
821: RESPIRATORY NEOPLASMS W CC 15629 0.20
822: RESPIRATORY NEOPLASMS W MCC 8705 0.11 … Parotitis or Benign Tumors 3040 0.04
DEN04: Gingival and Periodontal Disease 780 0.01
DEN05: Neoplasm
-
hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2013_MaskedStats_IP.PDF
January 01, 2013 - W MCC 7,591 0.18
181: RESPIRATORY NEOPLASMS W CC 7,001 0.17
182: RESPIRATORY NEOPLASMS W/O CC/MCC … FOR NEOPLASM W/O CC/MCC 64 0.00
659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W MCC 897 0.02
660 … : KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W CC 2,006 0.05
661: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM … W MCC 7,595 0.18
181: RESPIRATORY NEOPLASMS W CC 7,005 0.17
182: RESPIRATORY NEOPLASMS W/O CC/MCC … FOR NEOPLASM W/O CC/MCC 64 0.00
659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W MCC 900 0.02
660
-
hcup-us.ahrq.gov/toolssoftware/comorbidityicd10/comoanaly_icd10cm_2020_1.txt
January 01, 2020 - "HYPOTHY" "RENLFAIL" "LIVER"
"ULCER" "AIDS" "LYMPH" "METS" "TUMOR … **********************************************/
IF HTNCX = 1 THEN HTN = 0 ;
IF METS = 1 THEN TUMOR … AND CANCFLG THEN TUMOR = 0;
IF ARTH AND ARTHFLG THEN ARTH = 0;
IF COAG AND COAGFLG THEN COAG = … immune deficiency syndrome'
LYMPH = 'Lymphoma'
METS = 'Metastatic cancer … '
TUMOR = 'Solid tumor w/out metastasis'
ARTH = 'Rheumatoid arthritis
-
hcup-us.ahrq.gov/reports/statbriefs/sb228-Breast-Reconstruction-For-Mastectomy.pdf
June 01, 2016 - Choosing Between Reconstruction and “Going Flat” After Breast
Cancer. US News and World Report. … health-care/for-better/articles/2016-12-13/choosing-
between-reconstruction-and-going-flat-after-breast-cancer … Doing more:
trends in breast cancer surgery, 2005 to 2011. … Trends and variation in use of breast reconstruction in patients with breast cancer
undergoing mastectomy … Community hospitals include obstetrics and gynecology, otolaryngology,
orthopedic, cancer, pediatric